Calcineurin Inhibitors: all 995 studies that test it
Page 4 of 10. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant RecipientsCompletedNCT00284934Phase 3Results posted
- A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant PatientsCompletedNCT00282568Phase 2Results posted
- Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell TransplantationCompletedNCT00282282Phase 2Results posted
- A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant PatientsCompletedNCT00282256Phase 2Results posted
- A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant PatientsCompletedNCT00282243Phase 2Results posted
- Hematopoietic Stem Cell Support in VasculitisTerminatedNCT00278512Phase 1Results posted
- Study of ISA247 (Voclosporin) in De Novo Renal TransplantationCompletedNCT00270634Phase 2Results posted
- Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
- Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or TacrolimusTerminatedNCT00260208Phase 4Results posted
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerTerminatedNCT00255684Not applicableResults posted
- Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton SyndromeCompletedNCT00208026Phase 1/2Results posted
- Alemtuzumab to Treat Severe Aplastic AnemiaCompletedNCT00195624Phase 2Results posted
- A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant RecipientsCompletedNCT00195429Phase 4Results posted
- Allogeneic Transplantation From Related Haploidentical DonorsCompletedNCT00185692Phase 2Results posted
- Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
- ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant RecipientsCompletedNCT00170846Phase 4Results posted
- A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy ImmunosuppressionTerminatedNCT00166712Phase 4Results posted
- Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C InfectionCompletedNCT00163657Phase 4Results posted
- Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic RegimensCompletedNCT00157014Phase 3Results posted
- Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant PatientsCompletedNCT00154284Phase 3Results posted
- Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant RecipientsCompletedNCT00149994Phase 4Results posted
- Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative SteroidsCompletedNCT00149890Phase 3Results posted
- Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)CompletedNCT00135811Phase 3Results posted
- Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease ModificationTerminatedNCT00124709Phase 4Results posted
- S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed LymphomaTerminatedNCT00121186Phase 2Results posted
- 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic DermatitisCompletedNCT00120523Phase 3Results posted
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT00119366Phase 2Results posted
- Combination Therapy for Atopic DermatitisCompletedNCT00119158Phase 4Results posted
- Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver TransplantCompletedNCT00118742Phase 4Results posted
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00118352Phase 2Results posted
- Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNCT00112593Not applicableResults posted
- A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical ProstatectomyCompletedNCT00106392Phase 4Results posted
- Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation PatientsCompletedNCT00105235Phase 2Results posted
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerCompletedNCT00089011Phase 2Results posted
- Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant RecipientsTerminatedNCT00086346Phase 3Results posted
- Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in AdultsCompletedNCT00078559Phase 1/2Results posted
- Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell LymphomaTerminatedNCT00070291Phase 2Results posted
- Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic AnemiaCompletedNCT00065260Phase 2Results posted
- Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant RecipientsCompletedNCT00064701Phase 3Results posted
- Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedNCT00057954Phase 2Results posted
- Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00054353Phase 1/2Results posted
- NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersCompletedNCT00053989Phase 2Results posted
- S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid LeukemiaTerminatedNCT00053014Phase 2Results posted
- Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System CancersCompletedNCT00051311Phase 2Results posted
- Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerCompletedNCT00049504Phase 2Results posted
- Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in RemissionCompletedNCT00045435Phase 2Results posted
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesCompletedNCT00045305Phase 2Results posted
- Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric SarcomasCompletedNCT00043979Phase 2Results posted
- Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted KidneyCompletedNCT00035555Phase 2Results posted
- Islet Transplantation for Type 1 DiabetesCompletedNCT00014911Phase 2Results posted
- Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple MyelomaCompletedNCT00006184Phase 2Results posted
- Antithymocyte Globulin and Cyclosporine to Treat MyelodysplasiaCompletedNCT00005937Phase 2Results posted
- Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaCompletedNCT00005803Phase 1/2Results posted
- Specialized Blood Cell Transplants for Cancers of the Blood and Bone MarrowCompletedNCT00003838Phase 2Results posted
- Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003270Phase 2Results posted
- Stem Cell Transplantation for Metastatic Solid TumorsTerminatedNCT00001880Phase 2Results posted
- Tyrosine Vs Tacrolimus With NB-UVB in VitiligoCompletedNCT07532330Not applicable
- CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAAWithdrawnNCT07523009Phase 2
- Photobiomodulation in Combination With Topical Cyclosporine A or TacrolimusCompletedNCT07239128Early Phase 1
- Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy SubjectsActive, not recruitingNCT07196449Phase 1
- Intralesional Cyclosporine for Alopecia AreataActive, not recruitingNCT07029204Early Phase 1
- A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory TreatmentCompletedNCT07025811Phase 4
- Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye DiseaseCompletedNCT06876116Phase 4
- A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy AdultsCompletedNCT06837259Phase 1
- A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081CompletedNCT06809608Phase 1
- Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)CompletedNCT06638879Phase 1
- A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.CompletedNCT06541678Phase 1
- The COAT Trial: Cequa's Onset of Action TrialCompletedNCT06482177Phase 4
- A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic OintmentTerminatedNCT06400511Phase 3
- Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)WithdrawnNCT06246786Early Phase 1
- Improving Drop Instillation Comfort of a Cyclosporine A SolutionCompletedNCT05957211Not applicable
- Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness BurnsTerminatedNCT05856994Phase 1
- Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.CompletedNCT05771012Not applicable
- Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic KeratitisCompletedNCT05720715Phase 4
- Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SSStatus unknownNCT05694130Phase 2/3
- Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment ResponseStatus unknownNCT05692843Phase 4
- Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction SurgeryCompletedNCT05691764Not applicable
- Tacrolimus for Thrombocytopenia in SSStatus unknownNCT05678335Phase 2/3
- Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHDActive, not recruitingNCT05621759Phase 2
- A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus HydrocortisoneCompletedNCT05607901Phase 2
- An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant RecipientsTerminatedNCT05501574Phase 2
- Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)CompletedNCT05396898Phase 4
- Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell TransplantsActive, not recruitingNCT05364762Phase 2
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis TrialCompletedNCT05353101Phase 1
- A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy VolunteersStatus unknownNCT05353010Phase 1
- Tacrolimus Versus Hydrocortisone in Atopic DermatitisCompletedNCT05324618Phase 4
- Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD TreatmentCompletedNCT05294666Phase 4
- Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line TherapyStatus unknownNCT05221411Phase 4
- Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult ParticipantsCompletedNCT05202145Phase 1
- A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy VolunteersCompletedNCT05184517Early Phase 1
- A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on RilematovirCompletedNCT05155007Phase 1
- A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05153915Phase 4
- A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05152628Phase 4
- Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)Active, not recruitingNCT05148715Phase 2
- Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry EyeStatus unknownNCT05131152Not applicable
- A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy AdultsCompletedNCT05109390Phase 1
- NOMINATE/ Minimisation of Immunosuppression in Kidney TransplantationWithdrawnNCT05073822Phase 1/2
- Uses of Tacrolimus in Behcet DiseaseCompletedNCT05032248Not applicable
- Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University HospitalCompletedNCT04979884Phase 3
- ENvarsus for Impaired Glucose Tolerance Post REnal transplAnTWithdrawnNCT04973982Not applicable